Global acetylcysteine (CAS 6191) Market is expected to grow at a CAGR of XX% during the forecast period. The major factors driving the growth of this market are increasing incidence of paracetamol overdose, increasing number of patients with nephroprotective agent-induced hemorrhagic cystitis, and increasing number of patients with interstitial lung disease. However, high cost associated with acetylcysteine therapy may hamper the growth of this market.
The global acetylcysteine (CAS 6191) market is segmented on the basis of type into medical grade and industrial grade; on the basis of application into paracetamol overdose, mucolytic therapy, nephroprotective agent-induced hemorrhagic cystitis, microbiological applications such as tuberculosis and HIV infection treatment; on the basis of region into North America, Latin America, Europe Asia Pacific and Middle East & Africa; and by country including US, Canada Mexico Brazil Russia China India Japan South Korea Australia New Zealand Germany France UK Italy Spain Netherlands Belgium Austria Switzerland Sweden Finland Denmark Norway Ireland Poland Czech Republic Hungary Slovakia Slovenia Ukraine Belarus Latvia Lithuania Estonia Azerbaijan Georgia Armenia Azerbaijan Turkmenistan Uzbekistan Kazakhstan Kyrgyzstan Tajikistan Pakistan Iran Iraq Saudi Arabia Kuwait United Arab Emirates Qatar Oman Jordan Lebanon Syria Yemen Libya Sudan Nigeria Chad Niger Congo DR Congo Angola Kenya Uganda Tanzania Rwanda Burundi Eritrea Ethiopia Mozambique Zambia Zimbabwe Malawi Madagascar Comoros Djibouti Mauritania Mauritius Seychelles Reunion Island Mayotte Island Sao Tome And Principe Senegal Guinea-Bissau Equatorial Guinea Gabon Gambia Ghana Togo Benin Burkina Faso Ivory Coast Liberia Sierra Leone Senegal Guinea-Bissau Equatorial Guinea Gabon Gambia Ghana Togo Benin Burkina Faso Ivory Coast Liberia Sierra Leone.
N-acetylcysteine is a drug that is used to treat acetaminophen overdose. It is also used to prevent and treat chronic bronchitis, as well as other lung diseases.
Industry Growth Insights published a new data on “N-acetylcysteine (CAS 616-91-1) Market”. The research report is titled “N-acetylcysteine (CAS 616-91-1) Market research by Types (Medical Grade N-acetylcysteine, Industrial Grade N-acetylcysteine), By Applications (Paracetamol Overdose, Mucolytic Therapy, Nephroprotective Agent, Cyclophosphamide-induced Hemorrhagic Cystitis, Microbiological, Interstitial Lung Disease, Psychiatry), By Players/Companies BASF, WACKER, Cumberland Pharmaceuticals, Zambon, Bioniche Life Sciences, Manus Aktteva Biopharma, Hubei Shengbaolai Biological Technology, Ningbo Create-BIO ENGINEERING, XYS, Hubei Jusheng Technology, Wuhan Grand Hoyo, Wuhan Hezhong Bio-Chemical, Zhangjiagang Huachang Pharmaceutical, Zhangjiagang Shuguang Biological Factory, Donboo Amino Acid, WUXI ENOVO CHEMICAL, Ningbo Zhenhai Haide Amino Acid, Xinyi Hanling Biological Engineering, ZHANGJIAGANG SPECOM BIOCHEMICAL, Wuhan lullaby pharmaceutical chemical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
N-acetylcysteine (CAS 616-91-1) Market Research Report
By Type
Medical Grade N-acetylcysteine, Industrial Grade N-acetylcysteine
By Application
Paracetamol Overdose, Mucolytic Therapy, Nephroprotective Agent, Cyclophosphamide-induced Hemorrhagic Cystitis, Microbiological, Interstitial Lung Disease, Psychiatry
By Companies
BASF, WACKER, Cumberland Pharmaceuticals, Zambon, Bioniche Life Sciences, Manus Aktteva Biopharma, Hubei Shengbaolai Biological Technology, Ningbo Create-BIO ENGINEERING, XYS, Hubei Jusheng Technology, Wuhan Grand Hoyo, Wuhan Hezhong Bio-Chemical, Zhangjiagang Huachang Pharmaceutical, Zhangjiagang Shuguang Biological Factory, Donboo Amino Acid, WUXI ENOVO CHEMICAL, Ningbo Zhenhai Haide Amino Acid, Xinyi Hanling Biological Engineering, ZHANGJIAGANG SPECOM BIOCHEMICAL, Wuhan lullaby pharmaceutical chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global N-acetylcysteine (CAS 616-91-1) Market Report Segments:
The global N-acetylcysteine (CAS 616-91-1) market is segmented on the basis of:
Types
Medical Grade N-acetylcysteine, Industrial Grade N-acetylcysteine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Paracetamol Overdose, Mucolytic Therapy, Nephroprotective Agent, Cyclophosphamide-induced Hemorrhagic Cystitis, Microbiological, Interstitial Lung Disease, Psychiatry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BASF
- WACKER
- Cumberland Pharmaceuticals
- Zambon
- Bioniche Life Sciences
- Manus Aktteva Biopharma
- Hubei Shengbaolai Biological Technology
- Ningbo Create-BIO ENGINEERING
- XYS
- Hubei Jusheng Technology
- Wuhan Grand Hoyo
- Wuhan Hezhong Bio-Chemical
- Zhangjiagang Huachang Pharmaceutical
- Zhangjiagang Shuguang Biological Factory
- Donboo Amino Acid
- WUXI ENOVO CHEMICAL
- Ningbo Zhenhai Haide Amino Acid
- Xinyi Hanling Biological Engineering
- ZHANGJIAGANG SPECOM BIOCHEMICAL
- Wuhan lullaby pharmaceutical chemical
 Market Overview.svg)
Highlights of The N-acetylcysteine (CAS 616-91-1) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medical Grade N-acetylcysteine
- Industrial Grade N-acetylcysteine
- By Application:
- Paracetamol Overdose
- Mucolytic Therapy
- Nephroprotective Agent
- Cyclophosphamide-induced Hemorrhagic Cystitis
- Microbiological
- Interstitial Lung Disease
- Psychiatry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the N-acetylcysteine (CAS 616-91-1) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
N-acetylcysteine is a derivative of the amino acid cysteine. It is a water soluble molecule that can be taken by mouth or applied topically to the skin. N-acetylcysteine helps to protect cells from damage by acetaldehyde, a toxic byproduct of alcohol metabolism.
Some of the major companies in the n-acetylcysteine (cas 616-91-1) market are BASF, WACKER, Cumberland Pharmaceuticals, Zambon, Bioniche Life Sciences, Manus Aktteva Biopharma, Hubei Shengbaolai Biological Technology, Ningbo Create-BIO ENGINEERING, XYS, Hubei Jusheng Technology, Wuhan Grand Hoyo, Wuhan Hezhong Bio-Chemical, Zhangjiagang Huachang Pharmaceutical, Zhangjiagang Shuguang Biological Factory, Donboo Amino Acid, WUXI ENOVO CHEMICAL, Ningbo Zhenhai Haide Amino Acid, Xinyi Hanling Biological Engineering, ZHANGJIAGANG SPECOM BIOCHEMICAL, Wuhan lullaby pharmaceutical chemical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. N-acetylcysteine (CAS 616-91-1) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. N-acetylcysteine (CAS 616-91-1) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. N-acetylcysteine (CAS 616-91-1) Market - Supply Chain
4.5. Global N-acetylcysteine (CAS 616-91-1) Market Forecast
4.5.1. N-acetylcysteine (CAS 616-91-1) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. N-acetylcysteine (CAS 616-91-1) Market Size (000 Units) and Y-o-Y Growth
4.5.3. N-acetylcysteine (CAS 616-91-1) Market Absolute $ Opportunity
5. Global N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Type
5.3.1. Medical Grade N-acetylcysteine
5.3.2. Industrial Grade N-acetylcysteine
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Application
6.3.1. Paracetamol Overdose
6.3.2. Mucolytic Therapy
6.3.3. Nephroprotective Agent
6.3.4. Cyclophosphamide-induced Hemorrhagic Cystitis
6.3.5. Microbiological
6.3.6. Interstitial Lung Disease
6.3.7. Psychiatry
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global N-acetylcysteine (CAS 616-91-1) Demand Share Forecast, 2019-2026
9. North America N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Application
9.4.1. Paracetamol Overdose
9.4.2. Mucolytic Therapy
9.4.3. Nephroprotective Agent
9.4.4. Cyclophosphamide-induced Hemorrhagic Cystitis
9.4.5. Microbiological
9.4.6. Interstitial Lung Disease
9.4.7. Psychiatry
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Type
9.7.1. Medical Grade N-acetylcysteine
9.7.2. Industrial Grade N-acetylcysteine
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America N-acetylcysteine (CAS 616-91-1) Demand Share Forecast, 2019-2026
10. Latin America N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Application
10.4.1. Paracetamol Overdose
10.4.2. Mucolytic Therapy
10.4.3. Nephroprotective Agent
10.4.4. Cyclophosphamide-induced Hemorrhagic Cystitis
10.4.5. Microbiological
10.4.6. Interstitial Lung Disease
10.4.7. Psychiatry
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Type
10.7.1. Medical Grade N-acetylcysteine
10.7.2. Industrial Grade N-acetylcysteine
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America N-acetylcysteine (CAS 616-91-1) Demand Share Forecast, 2019-2026
11. Europe N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Application
11.4.1. Paracetamol Overdose
11.4.2. Mucolytic Therapy
11.4.3. Nephroprotective Agent
11.4.4. Cyclophosphamide-induced Hemorrhagic Cystitis
11.4.5. Microbiological
11.4.6. Interstitial Lung Disease
11.4.7. Psychiatry
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Type
11.7.1. Medical Gade N-acetylcysteine
11.7.2. Industrial Grade N-acetylcysteine
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe N-acetylcysteine (CAS 616-91-1) Demand Share, 2019-2026
12. Asia Pacific N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Application
12.4.1. Paracetamol Overdose
12.4.2. Mucolytic Therapy
12.4.3. Nephroprotective Agent
12.4.4. Cyclophosphamide-induced Hemorrhagic Cystitis
12.4.5. Microbiological
12.4.6. Interstitial Lung Disease
12.4.7. Psychiatry
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Type
12.7.1. Medical Grade N-acetylcysteine
12.7.2. Industrial Grade N-acetylcysteine
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific N-acetylcysteine (CAS 616-91-1) Demand Share, 2019-2026
13. Middle East & Africa N-acetylcysteine (CAS 616-91-1) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Application
13.4.1. Paracetamol Overdose
13.4.2. Mucolytic Therapy
13.4.3. Nephroprotective Agent
13.4.4. Cyclophosphamide-induced Hemorrhagic Cystitis
13.4.5. Microbiological
13.4.6. Interstitial Lung Disease
13.4.7. Psychiatry
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa N-acetylcysteine (CAS 616-91-1) Market Size and Volume Forecast by Type
13.7.1. Medical Grade N-acetylcysteine
13.7.2. Industrial Grade N-acetylcysteine
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa N-acetylcysteine (CAS 616-91-1) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global N-acetylcysteine (CAS 616-91-1) Market: Market Share Analysis
14.2. N-acetylcysteine (CAS 616-91-1) Distributors and Customers
14.3. N-acetylcysteine (CAS 616-91-1) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BASF
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. WACKER
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cumberland Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Zambon
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bioniche Life Sciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Manus Aktteva Biopharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hubei Shengbaolai Biological Technology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ningbo Create-BIO ENGINEERING
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. XYS
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hubei Jusheng Technology
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Wuhan Grand Hoyo
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Wuhan Hezhong Bio-Chemical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Zhangjiagang Huachang Pharmaceutical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Zhangjiagang Shuguang Biological Factory
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Donboo Amino Acid
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. WUXI ENOVO CHEMICAL
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Ningbo Zhenhai Haide Amino Acid
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Xinyi Hanling Biological Engineering
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. ZHANGJIAGANG SPECOM BIOCHEMICAL
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Wuhan lullaby pharmaceutical chemical
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
